Press Release: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

2 years ago

The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan’s LPT-CBD release technology, marking a key step in the advancement of non-opioid pain management HERZLIYA, Israel and CALGARY, AB, May 21, 2024 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), is pleased to announce significant advancements in the regulatory […]